ESC 365 - Doctor Karl-Patrik Kresoja

Speaker illustration

Doctor Karl-Patrik Kresoja

Heart Center of Leipzig, Leipzig (Germany)

Member of:

Heart Failure Association

Open panel discussion.

Event: ESC Congress 2022

Topic: Valvular Heart Disease

Session: HFpEF vs. HFrEF in patients with tricuspid regurgitation: does it matter for TTVr?

Current evidence for tricuspid repair across HF subtypes.

Event: ESC Congress 2022

Topic: Valvular Heart Disease

Session: HFpEF vs. HFrEF in patients with tricuspid regurgitation: does it matter for TTVr?

Machine learning to identify patients response to spironolactone treatment in patients with heart failure with preserved ejection fraction

Event: Heart Failure 2022

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: HFpEF: only one disease?

Effects of sympathetic modulation by renal denervation in patients with heart failure and preserved ejection fraction

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Pathophysiology

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Predicting in-hospital major bleeding in pulmonary embolism patients treated with systemic thrombolytic therapy

Event: ESC Congress 2018

Topic: Pulmonary Embolism (PE)

Session: Young Investigator Award Session Thrombosis

Validation of the VTE-BLEED score for predicting 30-day major bleeding in a real-world cohort of patients with pulmonary embolism

Event: ESC CONGRESS 2017

Topic: Acute pulmonary embolism

Session: After pulmonary embolism: optimising treatment and follow up

This platform is supported by